North America Cell Line Development Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line), Product (Equipment, and Media & Reagent), Application (Drug Discovery, Bioproduction, and Tissue Engineering), and Country

No. of Pages: 157    |    Report Code: TIPRE00020095    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Cell Line Development Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Cell Line Development Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Cell Line Development Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rise in Production of Vaccine
5.2 Market Opportunities
  • 5.2.1 Significant Opportunities in Emerging Market
5.3 Future Trends
  • 5.3.1 Ongoing Advancements in Cell Line Engineering and Robust Development in Cell Line Technology
5.4 Impact of Drivers and Restraints

6. North America Cell Line Development Market Regional Analysis

6.1 North America Cell Line Development Market Overview
6.2 North America Cell Line Development Market Revenue 2017-2027 (US$ Million)
6.3 North America Cell Line Development Market Forecast Analysis

7. North America Cell Line Development Market Analysis – by Type

7.1 Primary Cell Line
  • 7.1.1 Overview
  • 7.1.2 Primary Cell Line: North America Cell Line Development Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Hybridomas
  • 7.2.1 Overview
  • 7.2.2 Hybridomas: North America Cell Line Development Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Continuous Cell Lines
  • 7.3.1 Overview
  • 7.3.2 Continuous Cell Lines: North America Cell Line Development Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Recombinant Cell Line
  • 7.4.1 Overview
  • 7.4.2 Recombinant Cell Line: North America Cell Line Development Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Cell Line Development Market Analysis – by Product

8.1 Equipment
  • 8.1.1 Overview
  • 8.1.2 Equipment: North America Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Media & Reagent
  • 8.2.1 Overview
  • 8.2.2 Media & Reagent: North America Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)

9. North America Cell Line Development Market Analysis – by Application

9.1 Drug Discovery
  • 9.1.1 Overview
  • 9.1.2 Media & Reagent: North America Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Bioproduction
  • 9.2.1 Overview
  • 9.2.2 Media & Reagent: North America Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Tissue Engineering
  • 9.3.1 Overview
  • 9.3.2 Media & Reagent: North America Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)

10. North America Cell Line Development Market – North America Analysis

10.1 North America
  • 10.1.1 North America Cell Line Development Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 North America Cell Line Development Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 US: North America Cell Line Development Market Breakdown, by Type
    • 10.1.1.1.2 US: North America Cell Line Development Market Breakdown, by Product
    • 10.1.1.1.3 US: North America Cell Line Development Market Breakdown, by Application
  • 10.1.1.2 Canada: North America Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Canada: North America Cell Line Development Market Breakdown, by Type
    • 10.1.1.2.2 Canada: North America Cell Line Development Market Breakdown, by Product
    • 10.1.1.2.3 Canada: North America Cell Line Development Market Breakdown, by Application
  • 10.1.1.3 Mexico : North America Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Cell Line Development Market Breakdown, by Type
    • 10.1.1.3.2 Mexico : North America Cell Line Development Market Breakdown, by Product
    • 10.1.1.3.3 Mexico : North America Cell Line Development Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Cell Line Development Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Merck KGaA
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Thermo Fisher Scientific, Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Sartorius AG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 SELEXIS
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 BioFactura, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 WuXi AppTec
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 LakePharma, Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 General Electric
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Lonza
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Corning Incorporated
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. Merck KGaA
  2. Thermo Fisher Scientific, Inc.
  3. Sartorius AG
  4. SELEXIS
  5. BioFactura, Inc.
  6. WuXi AppTec
  7. LakePharma, Inc.
  8. General Electric
  9. Lonza
  10. Corning Incorporated
north-america-cell-line-development-market